Northrop Grumman's Q4 2023 sales increased by 6% to $10.6 billion, driven by strong demand across its sectors. However, the company reported a net loss of $535 million, or $3.54 per diluted share, due to a $1.56 billion pre-tax charge related to the B-21 program. Despite the net loss, the total backlog reached a record $84.2 billion.
Q4 sales increased 6 percent to $10.6 billion.
The company recorded a $1.56 billion pre-tax charge for the B-21 program.
Net loss totaled $535 million, or $3.54 per diluted share.
Total backlog rose to a record $84.2 billion.
Northrop Grumman introduced strong 2024 sales and margin guidance inline with prior outlook. The company reaffirms 2024 and 2025 free cash flow outlook and projects solid growth in 2026.
Visualization of income flow from segment revenue to net income